PCM
ABMD

Peregrine Capital Management’s Abiomed Inc ABMD Stock Holding History

Peregrine Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-119,773
Closed -$29.4M – 336
2022
Q3 		$29.4M Sell
119,773
-1,662
-1% -$449K 0.95% 14
2022
Q2 		$30.1M Sell
121,435
-7,700
-6% -$2.08M 0.91% 16
2022
Q1 		$42.8M Buy
+129,135
New +$39.8M 1.01% 17

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Peregrine Capital Management's ABMD Position: Q4 2022 in Review

Peregrine Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 119,773 shares — an estimated $29.4M sold.

Peregrine Capital Management first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $42.8M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Peregrine Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Peregrine Capital Management sold 119,773 Abiomed Inc shares in Q4 2022, an estimated $29.4M.
  • Peregrine Capital Management first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
  • Peregrine Capital Management's Abiomed Inc position peaked at $42.8M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.